Agape ATP (ATPC)
Market Price (12/20/2025): $0.1228 | Market Cap: $6.1 MilSector: Consumer Staples | Industry: Packaged Foods & Meats
Agape ATP (ATPC)
Market Price (12/20/2025): $0.1228Market Cap: $6.1 MilSector: Consumer StaplesIndustry: Packaged Foods & Meats
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Nutritional Supplements. | Weak multi-year price returns2Y Excs Rtn is -144%, 3Y Excs Rtn is -171% | Penny stockMkt Price is 0.1 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -2.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -189% | ||
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.5% | ||
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -192%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -192% | ||
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 347% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -49% | ||
| High stock price volatilityVol 12M is 246% | ||
| Key risksATPC key risks include [1] significant financial instability raising substantial going concern doubts, Show more. |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Nutritional Supplements. |
| Weak multi-year price returns2Y Excs Rtn is -144%, 3Y Excs Rtn is -171% |
| Penny stockMkt Price is 0.1 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -2.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -189% |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.5% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -192%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -192% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 347% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -49% |
| High stock price volatilityVol 12M is 246% |
| Key risksATPC key risks include [1] significant financial instability raising substantial going concern doubts, Show more. |
Valuation, Metrics & Events
ATPC Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
1. Significant Stock Price Decline in December 2025
Agape ATP's stock experienced a substantial drop, falling by -90.07% over a 10-day period leading up to December 19, 2025. On December 19, 2025, the stock price fell by -10.68% alone, from $0.137 to $0.122. The stock also recorded a 92.24% decrease "so far this year" as of December 17, 2025. Its lowest recorded stock price was $0.00 on December 3, 2025.
2. Company's Unexplained Volatility
On December 12, 2025, Agape ATP Corporation issued a statement addressing the recent volatility in its common stock. Management stated they were not aware of any material, undisclosed corporate developments or adverse operating conditions that would explain the recent share price fluctuations.
3. Declining Revenue and Persistent Losses
The company's financial performance showed a decline, with revenue for the third quarter of 2025 falling to $370,590 from $465,500 in the second quarter. Agape ATP also reported a loss of $0.01 per share for the third quarter, consistent with the loss from the prior quarter.
4. Bearish Technical Outlook
Technical analysis indicators as of December 15, 2025, showed a bearish sentiment for ATPC, with 24 bearish signals and no bullish signals. Furthermore, as of December 19, 2025, the stock held sell signals from both short and long-term Moving Averages, contributing to a negative forecast.
5. Small Market Capitalization and High Volatility
Agape ATP Corporation had a market capitalization of approximately $4.55 million as of December 17, 2025. This small market capitalization often indicates a micro-cap stock, which can be highly susceptible to significant price fluctuations and volatility, as evidenced by its 52-week trading range of $0.05 to $2.93.
Stock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| ATPC Return | 14% | 7% | -50% | -84% | -91% | -88% | -100% |
| Peers Return | � | � | � | � | � | � | � |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 16% | 112% |
Monthly Win Rates [3] | |||||||
| ATPC Win Rate | 17% | 8% | 0% | 25% | 25% | 42% | |
| Peers Win Rate | � | � | � | � | � | 33% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| ATPC Max Drawdown | -2% | 0% | -50% | -84% | -91% | -94% | |
| Peers Max Drawdown | � | � | � | � | � | � | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: K, GIS, FLO, WEST, MEHA.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/19/2025 (YTD)
How Low Can It Go
| Event | ATPC | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -93.0% | -25.4% |
| % Gain to Breakeven | 1325.9% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -7.1% | -33.9% |
| % Gain to Breakeven | 7.7% | 51.3% |
| Time to Breakeven | 69 days | 148 days |
| 2018 Correction | ||
| % Loss | -88.0% | -19.8% |
| % Gain to Breakeven | 730.0% | 24.7% |
| Time to Breakeven | 1,428 days | 120 days |
Compare to K, GIS, FLO, WEST, MEHA
In The Past
Agape ATP's stock fell -93.0% during the 2022 Inflation Shock from a high on 9/11/2023. A -93.0% loss requires a 1325.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
| Title | Topic | |
|---|---|---|
| DASHBOARDS | ||
| Is Agape ATP Stock Built to Withstand More Downside? | Return |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select past ideas related to ATPC. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11302025 | BF-B | Brown-Forman | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -0.9% | -0.9% | -0.9% |
| 11302025 | CPB | Campbell's | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -6.2% | -6.2% | -7.5% |
| 11212025 | ENR | Energizer | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 10.3% | 10.3% | -5.3% |
| 11212025 | FLO | Flowers Foods | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 5.8% | 5.8% | -1.6% |
| 11142025 | CLX | Clorox | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.2% | -5.2% | -5.2% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11302025 | BF-B | Brown-Forman | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -0.9% | -0.9% | -0.9% |
| 11302025 | CPB | Campbell's | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -6.2% | -6.2% | -7.5% |
| 11212025 | ENR | Energizer | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 10.3% | 10.3% | -5.3% |
| 11212025 | FLO | Flowers Foods | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 5.8% | 5.8% | -1.6% |
| 11142025 | CLX | Clorox | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.2% | -5.2% | -5.2% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Agape ATP
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 4.19 |
| Mkt Cap | 2.3 |
| Rev LTM | 3,107 |
| Op Inc LTM | 160 |
| FCF LTM | 163 |
| FCF 3Y Avg | 257 |
| CFO LTM | 226 |
| CFO 3Y Avg | 384 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.9% |
| Rev Chg 3Y Avg | 1.5% |
| Rev Chg Q | 7.4% |
| QoQ Delta Rev Chg LTM | 1.7% |
| Op Mgn LTM | 1.5% |
| Op Mgn 3Y Avg | 5.7% |
| QoQ Delta Op Mgn LTM | 0.2% |
| CFO/Rev LTM | 9.6% |
| CFO/Rev 3Y Avg | 7.5% |
| FCF/Rev LTM | 5.7% |
| FCF/Rev 3Y Avg | 5.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 2.3 |
| P/S | 1.4 |
| P/EBIT | 7.1 |
| P/E | 10.1 |
| P/CFO | 5.1 |
| Total Yield | 7.3% |
| Dividend Yield | 2.7% |
| FCF Yield 3Y Avg | 3.6% |
| D/E | 0.5 |
| Net D/E | 0.5 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 0.5% |
| 3M Rtn | -16.1% |
| 6M Rtn | -29.0% |
| 12M Rtn | -38.9% |
| 3Y Rtn | -60.5% |
| 1M Excs Rtn | -2.4% |
| 3M Excs Rtn | -18.0% |
| 6M Excs Rtn | -43.0% |
| 12M Excs Rtn | -55.1% |
| 3Y Excs Rtn | -134.6% |
Segment Financials
Revenue by Segment
| $ Mil | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Skin care, Health and Wellness | 1 | |||
| Green Energy | 0 | |||
| Others | 0 | |||
| ATPR Mito+ | 0 | 0 | ||
| Beta Maxx | 0 | 0 | 0 | |
| Energetique | 0 | 0 | 0 | |
| Health and Wellness services | 0 | 0 | ||
| Ionized Cal-Mag | 0 | 0 | 1 | |
| Iron | 0 | 0 | 0 | |
| LIVO 5 | 0 | |||
| Mix Soy Protein Isolate Powder with Black Sesame | 0 | |||
| Omega Blend | 0 | 0 | 0 | |
| Other | 0 | |||
| Others - Products for the provision of complementary health therapies | 1 | |||
| Soy Protein Isolate Powder | 0 | |||
| Survivor Select | 0 | 0 | 0 | |
| Trim+ | 0 | 0 | 0 | |
| Young Formula | 0 | 0 | 1 | |
| Energized Mineral Concentrate | 0 | 0 | ||
| Lipomask | 0 | |||
| Organic Youth Care Cleansing Bar | 0 | 0 | ||
| Vege Fruit Fiber | 0 | 0 | ||
| Mitogize | 0 | |||
| No. 1 MED | 0 | |||
| Total | 1 | 2 | 1 | 3 |
| $ Mil | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Green Energy | 0 | |||
| Others | -1 | |||
| Skin care, Health and Wellness | -1 | |||
| Total | -2 |
| $ Mil | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Others | 5 | |||
| Skin care, Health and Wellness | 1 | |||
| Green Energy | 0 | |||
| Total | 6 |
Returns Analyses
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11132025 | 10-Q 9/30/2025 |
| 6302025 | 8132025 | 10-Q 6/30/2025 |
| 3312025 | 5152025 | 10-Q 3/31/2025 |
| 12312024 | 3312025 | 10-K 12/31/2024 |
| 9302024 | 11142024 | 10-Q 9/30/2024 |
| 6302024 | 8142024 | 10-Q 6/30/2024 |
| 3312024 | 5142024 | 10-Q 3/31/2024 |
| 12312023 | 4012024 | 10-K 12/31/2023 |
| 9302023 | 11142023 | 10-Q 9/30/2023 |
| 6302023 | 8142023 | 10-Q 6/30/2023 |
| 3312023 | 5152023 | 10-Q 3/31/2023 |
| 12312022 | 3312023 | 10-K 12/31/2022 |
| 9302022 | 11142022 | 10-Q 9/30/2022 |
| 6302022 | 8112022 | 10-Q 6/30/2022 |
| 3312022 | 5132022 | 10-Q 3/31/2022 |
| 12312021 | 3282022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |